Bruno Mahut, Plamen Bokov, Nicole Beydon, Christophe Delclaux
{"title":"在哮喘儿童开放队列中使用FEV1条件变化评分检测肺生长受损","authors":"Bruno Mahut, Plamen Bokov, Nicole Beydon, Christophe Delclaux","doi":"10.1002/ppul.71295","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It has been suggested that a quarter of children with asthma show impaired lung growth, with better initial function as a risk factor. A conditional change score (CCS) for FEV<sub>1</sub> that is independent of the initial FEV<sub>1</sub> and that takes into account the time interval between the measurements has been proposed, a value < -1.96 being predictive of impaired growth.</p><p><strong>Objective: </strong>To evaluate whether the use of the CCS allows the identification of a subgroup of children with asthma that has an impaired lung growth, and to identify the risk factors of impaired growth.</p><p><strong>Methods: </strong>We reanalyzed the data of 295 children with confirmed asthma (199 boys) who had undergone at least 10 spirometry tests from the age of 8 who were selected from a single-center open cohort. The annualized rate of change (slope) for prebronchodilator FEV<sub>1</sub> (percent predicted) was estimated for each participant. Using the first and last visit of follow-up, the CCS was calculated.</p><p><strong>Results: </strong>In total, 46 children (16%, 95% confidence interval: 12-20) followed up for a median duration of 6.5 years [interquartile: 5.7-7.3] exhibited an impaired lung growth. The CCS correlated with the standard deviation of individual slopes (FEV<sub>1</sub> variability criterion: R = 0.21; p < 0.001), the z-score of FEV<sub>1</sub> at first visit (R = -0.22; p < 0.001), and the body mass index at final visit (R = 0.16; p = 0.005), which remained independently associated with the CCS.</p><p><strong>Conclusion: </strong>We confirm that some children with asthma (16%) show impaired lung growth with better initial lung function and decreased FEV<sub>1</sub> variability as risk factors.</p>","PeriodicalId":19932,"journal":{"name":"Pediatric Pulmonology","volume":"60 9","pages":"e71295"},"PeriodicalIF":2.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439321/pdf/","citationCount":"0","resultStr":"{\"title\":\"Detecting Impaired Lung Growth Using the Conditional Change Score of FEV<sub>1</sub> in an Open Cohort of Children With Asthma.\",\"authors\":\"Bruno Mahut, Plamen Bokov, Nicole Beydon, Christophe Delclaux\",\"doi\":\"10.1002/ppul.71295\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It has been suggested that a quarter of children with asthma show impaired lung growth, with better initial function as a risk factor. A conditional change score (CCS) for FEV<sub>1</sub> that is independent of the initial FEV<sub>1</sub> and that takes into account the time interval between the measurements has been proposed, a value < -1.96 being predictive of impaired growth.</p><p><strong>Objective: </strong>To evaluate whether the use of the CCS allows the identification of a subgroup of children with asthma that has an impaired lung growth, and to identify the risk factors of impaired growth.</p><p><strong>Methods: </strong>We reanalyzed the data of 295 children with confirmed asthma (199 boys) who had undergone at least 10 spirometry tests from the age of 8 who were selected from a single-center open cohort. The annualized rate of change (slope) for prebronchodilator FEV<sub>1</sub> (percent predicted) was estimated for each participant. Using the first and last visit of follow-up, the CCS was calculated.</p><p><strong>Results: </strong>In total, 46 children (16%, 95% confidence interval: 12-20) followed up for a median duration of 6.5 years [interquartile: 5.7-7.3] exhibited an impaired lung growth. The CCS correlated with the standard deviation of individual slopes (FEV<sub>1</sub> variability criterion: R = 0.21; p < 0.001), the z-score of FEV<sub>1</sub> at first visit (R = -0.22; p < 0.001), and the body mass index at final visit (R = 0.16; p = 0.005), which remained independently associated with the CCS.</p><p><strong>Conclusion: </strong>We confirm that some children with asthma (16%) show impaired lung growth with better initial lung function and decreased FEV<sub>1</sub> variability as risk factors.</p>\",\"PeriodicalId\":19932,\"journal\":{\"name\":\"Pediatric Pulmonology\",\"volume\":\"60 9\",\"pages\":\"e71295\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439321/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Pulmonology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ppul.71295\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ppul.71295","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
Detecting Impaired Lung Growth Using the Conditional Change Score of FEV1 in an Open Cohort of Children With Asthma.
Background: It has been suggested that a quarter of children with asthma show impaired lung growth, with better initial function as a risk factor. A conditional change score (CCS) for FEV1 that is independent of the initial FEV1 and that takes into account the time interval between the measurements has been proposed, a value < -1.96 being predictive of impaired growth.
Objective: To evaluate whether the use of the CCS allows the identification of a subgroup of children with asthma that has an impaired lung growth, and to identify the risk factors of impaired growth.
Methods: We reanalyzed the data of 295 children with confirmed asthma (199 boys) who had undergone at least 10 spirometry tests from the age of 8 who were selected from a single-center open cohort. The annualized rate of change (slope) for prebronchodilator FEV1 (percent predicted) was estimated for each participant. Using the first and last visit of follow-up, the CCS was calculated.
Results: In total, 46 children (16%, 95% confidence interval: 12-20) followed up for a median duration of 6.5 years [interquartile: 5.7-7.3] exhibited an impaired lung growth. The CCS correlated with the standard deviation of individual slopes (FEV1 variability criterion: R = 0.21; p < 0.001), the z-score of FEV1 at first visit (R = -0.22; p < 0.001), and the body mass index at final visit (R = 0.16; p = 0.005), which remained independently associated with the CCS.
Conclusion: We confirm that some children with asthma (16%) show impaired lung growth with better initial lung function and decreased FEV1 variability as risk factors.
期刊介绍:
Pediatric Pulmonology (PPUL) is the foremost global journal studying the respiratory system in disease and in health as it develops from intrauterine life though adolescence to adulthood. Combining explicit and informative analysis of clinical as well as basic scientific research, PPUL provides a look at the many facets of respiratory system disorders in infants and children, ranging from pathological anatomy, developmental issues, and pathophysiology to infectious disease, asthma, cystic fibrosis, and airborne toxins. Focused attention is given to the reporting of diagnostic and therapeutic methods for neonates, preschool children, and adolescents, the enduring effects of childhood respiratory diseases, and newly described infectious diseases.
PPUL concentrates on subject matters of crucial interest to specialists preparing for the Pediatric Subspecialty Examinations in the United States and other countries. With its attentive coverage and extensive clinical data, this journal is a principle source for pediatricians in practice and in training and a must have for all pediatric pulmonologists.